Online article focuses on MJNA’s international subsidiaries and the company’s role in bringing CBD oil products to the world.
Medical Marijuana, Inc. and its portfolio of companies were a central part of a recent article published on MMJ Reporter exploring the worldwide operations of international divisions like HempMeds® Brasil and HempMeds® Mexico. Through these local companies in Brazil and Mexico, MJNA was the first company to legally ship CBD products to these two countries.
MMJ Reporter is a leading online media source for topics covering technology, health, biotech, and finance and business news for the medical cannabis industry. Its piece covering Medical Marijuana, Inc. was published online on October 31st.
Bringing CBD to Brazil
Medical Marijuana, Inc. first broke ground for the medical use of cannabis in Brazil following a court case by a family there fighting for the right to give their daughter CBD oil. After HempMeds® Brasil launched in the country, the company worked to educate local lawmakers, cannabis advocates, and families hoping for access to CBD. The end goal was to generate awareness for CBD oil and to help shift public perception in favor of CBD.
Now, CBD oil is legal in Brazil with a doctor’s prescription and import authorization from the government and fully subsidized by the country’s healthcare system. The company works hand in hand with patients and doctors there to assist them in navigating the import process.
Medical Cannabis Legalization in Mexico
Medical Marijuana, Inc. next duplicated this process in Mexico after Raul Elizalde successfully fought the government to import CBD for his daughter, creating the Por Grace Foundation along the way. HempMeds® Mexico would team with Raul and Por Grace to raise awareness for CBD in Mexico and to lobby for its use.
After being invited by Mexican President Peña Nieto to speak prior to the President’s announcement that the country would be pursuing medical cannabis reform, Raul would take the reigns of HempMeds® Mexico and lead the expansion of its operations. Raul will bring his knowledge and experience with CBD to the WHO Thirty-Ninth meeting of the Expert Committee on Drug Dependence next week.
MJNA Stock Trading Up
According to the article in MMJ Reporter, Medical Marijuana, Inc.’s stock closed up in trading for the period before the article’s publication. This growth trend is expected to continue as the CBD oil market is projected to grow to $1 billion by 2020.
You can read more about the Medical Marijuana, Inc. portfolio of companies and the immense potential in hemp-derived CBD on our news feed.